
Merck & Co. Inc (MRK) is a leading drug manufacturers-general business based in the US. It opened the day at USD$81.6 after a previous close of USD$81.32. During the day the price has varied from a low of USD$80.765 to a high of USD$81.8521. The latest price was USD$81.38 (25 minute delay). Merck is listed on the NYSE and employs 67,000 staff. All prices are listed in US Dollars.
Compare online trading platforms
What's in this guide?
- Merck shares summary
- Compare share dealing platforms
- Is Merck stock a buy or sell?
- Merck performance over time
- Is Merck suitable for ethical investing?
- Are Merck shares over-valued?
- Merck's financials
- How volatile are Merck shares?
- Does Merck pay a dividend?
- Have Merck shares ever split?
- Other common questions
How has Coronavirus impacted Merck's stock price?
Since the stock market crash in March caused by coronavirus, Merck's stock price has had significant positive movement.
Its last market close was $93.55, which is 11.98% up on its pre-crash value of $82.34 and 43.37% up on the lowest point reached during the March crash when the stocks fell as low as $65.25.
If you had bought $1,000 worth of Merck stocks at the start of February 2020, those stocks would have been worth $760.28 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,071.15.
Is it a good time to buy Merck stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Merck shares at a glance
Open | $81.60 |
---|---|
High | $81.85 |
Low | $80.77 |
Close | $81.38 |
Previous close | $81.32 |
Change | $0.06 |
Change % | 0.0738% |
Volume | 9,478,020 |
52-week range | $69.02 - $92.87 |
---|---|
50-day moving average | $83.76 |
200-day moving average | $79.51 |
Wall St. target price | $95.73 |
PE ratio | 16.1822 |
Dividend yield | $2.64 (3.05%) |
Earnings per share (TTM) | $5.59 |
Merck stock price (NYSE:MRK)
Use our graph to track the performance of MRK stocks over time.Merck price performance over time
Historical closes compared with the close of $81.38 from 2022-05-20
1 week (2022-05-16) | -11.85% |
---|---|
1 month (2022-04-22) | -3.79% |
3 months (2022-02-19) | N/A |
6 months (2021-11-23) | -1.71% |
1 year (2021-05-21) | 2.78% |
---|---|
2 years (2020-05-22) | 6.64% |
3 years (2019-05-22) | 0.57% |
5 years (2017-05-22) | 27.17% |
Is Merck under- or over-valued?
Valuing Merck stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Merck's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Merck's P/E ratio
Merck's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Merck shares trade at around 16x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Merck's PEG ratio
Merck's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1542. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Merck's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Merck's EBITDA
Merck's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $21.6 billion.
The EBITDA is a measure of a Merck's overall financial performance and is widely used to measure a its profitability.
Merck financials
Revenue TTM | $54 billion |
---|---|
Operating margin TTM | 34.41% |
Gross profit TTM | $35.5 billion |
Return on assets TTM | 10.05% |
Return on equity TTM | 38.82% |
Profit margin | 26.27% |
Book value | $15.11 |
Market capitalisation | $228.6 billion |
TTM: trailing 12 months
Merck's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Merck.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Merck's total ESG risk score
Total ESG risk: 28.35
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Merck's overall score of 28.35 (as at 12/31/2018) is nothing to write home about – landing it in it in the 47th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Merck is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Merck's environmental score
Environmental score: 3.15/100
Merck's environmental score of 3.15 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that Merck is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Merck's social score
Social score: 15.55/100
Merck's social score of 15.55 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that Merck is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Merck's governance score
Governance score: 12.65/100
Merck's governance score puts it squarely in the 4th percentile of companies rated in the same sector. That could suggest that Merck is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Merck's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Merck scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Merck hasn't always managed to keep its nose clean.
Merck share dividends
Dividend payout ratio: 38.29% of net profits
Recently Merck has paid out, on average, around 38.29% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.05% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Merck shareholders could enjoy a 3.05% return on their shares, in the form of dividend payments. In Merck's case, that would currently equate to about $2.64 per share.
While Merck's payout ratio might seem fairly standard, it's worth remembering that Merck may be investing much of the rest of its net profits in future growth.
Merck's most recent dividend payout was on 6 April 2022. The latest dividend was paid out to all shareholders who bought their shares by 13 March 2022 (the "ex-dividend date").
Have Merck's shares ever split?
Merck's shares were split on a 1048:1000 basis on 2 June 2021. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1048 shares. This wouldn't directly have changed the overall worth of your Merck shares – just the quantity. However, indirectly, the new 4.6% lower share price could have impacted the market appetite for Merck shares which in turn could have impacted Merck's share price.
Merck share price volatility
Over the last 12 months, Merck's shares have ranged in value from as little as $69.0248 up to $92.87. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Merck's is 0.4608. This would suggest that Merck's shares are less volatile than average (for this exchange).
Merck overview
Merck & Co. , Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers.
Shares similar to Merck
Frequently asked questions
Merck in the news

7 Quality Dividend Stocks to Buy on the Dip

7 Retirement Stocks That Can Hold Up Against the Fire
CHMP Supports Approval Of Merck's Keytruda As Adjuvant In Post Surgery Melanoma Setting
More guides on Finder
-
How India will be investing in 2022
Finder’s Retail Investor Sentiment Report polled 39,573 Internet users across 26 countries to see how they’ll be investing their money in 2022.
-
How to invest in the S&P 500 from India
Find out the different ways you can invest in the S&P 500, one of the world’s most popular stock market indices.
-
ETFs vs index funds
Find out about what ETFs and index funds are, their key similarities and differences, as well as how to invest in these passive funds.
-
How to invest in gold ETFs in India
Find out about gold ETFs, what influences their prices, how you can trade them and whether they could be worth your weight in gold.
-
How to invest money
Learn the basics of what it takes for novices to get started in the investment world in India, including an overview of your options and what to watch out for.
-
How to buy N/A (N/A) shares in India
Steps to owning and managing N/A, with 24-hour and historical pricing before you buy.
-
How to buy N/A (N/A) shares in India
Steps to owning and managing N/A, with 24-hour and historical pricing before you buy.
-
How to invest in oil in India
Learn about the four options available to buy and sell this slippery commodity — as well as pros and cons.
-
How to buy N/A (N/A) shares in India
Steps to owning and managing N/A, with 24-hour and historical pricing before you buy.
-
How to buy Bitcoin ETFs from India
Bitcoin ETFs are coming to market. Here’s how you can invest in them.
Ask an Expert